BERLIN, May 6 (Reuters) – A German government spokesperson said on Wednesday that the loss of BioNTech vaccine production in the country can be offset by other companies.
He added that the government continues to assume that the vaccine supply to the population is guaranteed.
BioNTech this week said it would close sites affecting up to 1,860 jobs, as the COVID-19 vaccine maker pivots away from pandemic-era manufacturing.
(Reporting by Thomas SeythalEditing by Madeline Chambers)
